These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16188436)

  • 1. The role of dydrogesterone in recurrent (habitual) abortion.
    Gruber CJ; Huber JC
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):426-30. PubMed ID: 16188436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of cytokine production by dydrogesterone in lymphocytes from women with recurrent miscarriage.
    Raghupathy R; Al Mutawa E; Makhseed M; Azizieh F; Szekeres-Bartho J
    BJOG; 2005 Aug; 112(8):1096-101. PubMed ID: 16045524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral dydrogesterone treatment during the first trimester of pregnancy: the prevention of miscarriage study (PROMIS). A double-blind, prospectively randomized, placebo-controlled, parallel group trial.
    Walch K; Hefler L; Nagele F
    J Matern Fetal Neonatal Med; 2005 Oct; 18(4):265-9. PubMed ID: 16318978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.
    Kalinka J; Szekeres-Bartho J
    Am J Reprod Immunol; 2005 Apr; 53(4):166-71. PubMed ID: 15760377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dydrogesterone supplementation in women with threatened preterm delivery--the impact on cytokine profile, hormone profile, and progesterone-induced blocking factor.
    Hudić I; Szekeres-Bartho J; Fatušić Z; Stray-Pedersen B; Dizdarević-Hudić L; Latifagić A; Hotić N; Kamerić L; Mandžić A
    J Reprod Immunol; 2011 Dec; 92(1-2):103-7. PubMed ID: 22032897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological aspect of spontaneous and habitual abortion].
    Fatusić Z
    Med Arh; 2006; 60(2):129-31. PubMed ID: 16528935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of Cytokine Production by the Dydrogesterone Metabolite Dihydrodydrogesterone.
    Raghupathy R; Al-Azemi M
    Am J Reprod Immunol; 2015 Nov; 74(5):419-26. PubMed ID: 26250154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study.
    Ghosh S; Chattopadhyay R; Goswami S; Chaudhury K; Chakravarty B; Ganesh A
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery.
    Raghupathy R; Al-Mutawa E; Al-Azemi M; Makhseed M; Azizieh F; Szekeres-Bartho J
    J Reprod Immunol; 2009 Jun; 80(1-2):91-9. PubMed ID: 19371956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
    Hudić I; Fatusić Z
    J Perinat Med; 2009; 37(4):338-42. PubMed ID: 19290853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analyses of cytokine profiles reveal hormone-mediated modulation of cytokine profiles in recurrent spontaneous miscarriage.
    Dingle K; Kassem OM; Azizieh F; AbdulHussain G; Raghupathy R
    Cytokine; 2023 Apr; 164():156160. PubMed ID: 36804258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of dydrogesterone supplementation on serum cytokine profile in women with threatened abortion.
    Kalinka J; Radwan M
    Am J Reprod Immunol; 2006 Feb; 55(2):115-21. PubMed ID: 16433830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokines, Hormones and Cellular Regulatory Mechanisms Favoring Successful Reproduction.
    Piccinni MP; Raghupathy R; Saito S; Szekeres-Bartho J
    Front Immunol; 2021; 12():717808. PubMed ID: 34394125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone and the immunology of pregnancy.
    Druckmann R; Druckmann MA
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):389-96. PubMed ID: 16198558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dydrogesterone in threatened miscarriage: a Malaysian experience.
    Pandian RU
    Maturitas; 2009 Dec; 65 Suppl 1():S47-50. PubMed ID: 20005647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of dydrogesterone on treating recurrent miscarriage and its influence on immune factors: a systematic review and meta-analysis.
    Guo H; Lu Q
    Ann Palliat Med; 2021 Oct; 10(10):10971-10985. PubMed ID: 34763460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dydrogesterone in the reduction of recurrent spontaneous abortion.
    El-Zibdeh MY
    J Steroid Biochem Mol Biol; 2005 Dec; 97(5):431-4. PubMed ID: 16253504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of dydrogesterone for the treatment of recurrent miscarriage.
    Carp H
    Gynecol Endocrinol; 2015 Jun; 31(6):422-30. PubMed ID: 25765519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th1 and Th2 cytokine profiles in recurrent aborters may merely reflect the progesterone status.
    Check JH
    Hum Reprod; 2002 Jun; 17(6):1669-70; author reply 1670-1. PubMed ID: 12042296
    [No Abstract]   [Full Text] [Related]  

  • 20. Dydrogesterone and the immunology of pregnancy.
    Raghupathy R; Szekeres-Bartho J
    Horm Mol Biol Clin Investig; 2016 Aug; 27(2):63-71. PubMed ID: 26812877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.